HCFA Makes Public Near-Final Coverage Decisions On Three Devices
This article was originally published in The Gray Sheet
The first evidence of a more open Medicare coverage process appeared on the Health Care Financing Administration's web site Feb. 3, as the agency posted coverage information for four devices: cardiac monitoring by electrical bioimpedance, external counterpulsation, transmyocardial revascularization, and positron emission tomography.
You may also be interested in...
Thoracic electrical bioimpedance (TEB) for treating drug-resistant hypertension is left to local carrier discretion, CMS states in an 1Aug. 7 national coverage determination decision memo. On the same day, the agency issued a national non-coverage policy for TEB in managing all other forms of hypertension. Six indications of TEB are already covered under an NCD (2"The Gray Sheet" Feb. 8, 1999, p. 7). CardioDynamics offers the BioZ impedance cardiography (ICG) test...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.